Skip to Content


Children's Cancer Hospital research highlights

CCH Newsletter - Spring 2012

MD Anderson Children’s Cancer Hospital is focusing on understanding each cancer at the molecular level so that more targeted treatments with less toxicity can be found.

As molecular pathways that are abnormal in different childhood cancers are defined, investigators can better determine which new therapies developed for adult cancers may apply to treating pediatric patients.

In addition, the Children’s Cancer Hospital is investigating immunotherapies and cell therapies as treatments for metastases and for eliminating residual microscopic disease after conventional treatments.

Here’s a summary of Children’s Cancer Hospital research highlights for 2011.

If you’re interested in learning more about any of these studies, call the Children’s Cancer Hospital at 713-792-5410 to speak directly with an investigator.

© 2015 The University of Texas MD Anderson Cancer Center